AKRX News and Press, Akorn Inc. From 11/01/19

Image source: The Motley Fool. Akorn   (NASDAQ: AKRX) Q3 2019 Earnings Call Oct 31, 2019 , 10:00 a.m. ET Operator Continue reading

Akorn, Inc. (AKRX) Q3 2019 Earnings Conference Call October 31, 2019, 10:00 ET Company Participants Jennifer Bowles - SVP, Corporate Strategy Douglas Boothe - President, CEO & Director Duane Portwood - EVP & CFO Conference Call Participants David Amsellem - Piper Ja...

Akorn ( AKRX +1.7% ) is up in early trade, albeit on light volume, on the heels of preliminary Q3 results . Highlights: More news on: Akorn, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Akorn (NASDAQ: AKRX ): Q3 Non-GAAP EPS of $0.02 beats by $0.06 ; GAAP EPS of $0.38 beats by $0.71 . More news on: Akorn, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

LAKE FOREST, Ill., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced its preliminary financial results for the third quarter of 2019. Third Quarter 2019 and Recent Business Highlights Net revenue was $176 million...

The FDA approves Akorn's (NASDAQ: AKRX ) betamethasone dipropionate lotion USP (augmented), 0.05%, a topical corticosteroid for the treatment of inflammatory skin conditions. More news on: Akorn, Inc., Healthcare stocks news, Stocks on the move, Read more ...

LAKE FOREST, Ill., Oct. 14, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it received a new Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for betamethasone diprop...

LAKE FOREST, Ill., Oct. 14, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it plans to issue a press release before market open on Thursday, October 31, 2019 outlining its third quarter 2019 financial resu...

After losing more than 77% of its total enterprise value in less than four years, Akorn, Inc. ( AKRX ) is a name to be followed carefully. The most significant risk is the company’s financial debt, which does not justify the current low valuation. Besides, Akorn recently announced tha...

Gainers: Helios and Matheson Analytics ( OTCPK:HMNY ) +42% . McDermott International (NYSE: MDR ) +31% . Midatech Pharma plc (NASDAQ: MTP ) +30% . Stage Store (NYSE: SSI ) +26% . San Juan Basin Royalty Trust (NYSE: SJT ) +20% . Interlink Electronics ( OTCPK:LINK ) +20% . California ...